研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2025 年的期刊文章 · 第 18 页
共 1491 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2025-05-29 到 2025-05-19。
按期刊、按主题看 →
SMMR Survival Analysis Longitudinal Data Bayesian Methods · 发表于 2025-05-29
Danilo Alvares, Cristian Meza, Rolando De la Cruz
摘要
Motivated by a pregnancy miscarriage study, we propose a Bayesian joint model for longitudinal and time-to-event outcomes that takes into account different complexities of the problem. In particular, the longitudinal process is modeled by means of a nonlinear specification with subject-specific error variance. In addition, the exact time of fetal death is unknown, and a subgroup of women is not susceptible to miscarriage. Hence, we model the survival process via a mixture cure model for interval-censored data. Finally, both processes are linked through the subject-specific longitudinal mean and variance. A simulation study is conducted in order to validate our joint model. In the real application, we use individual weighted and Cox-Snell residuals to assess the goodness-of-fit of our proposal versus a joint model that shares only the subject-specific longitudinal mean (standard approach). In addition, the leave-one-out cross-validation criterion is applied to compare the predictive ability of both models.
SMMR Diagnostics & Prediction · 发表于 2025-05-29
Mark A van de Wiel, Gwenaël GR Leday, Martijn W Heymans, Erik W van Zwet, Ailko H Zwinderman, Jeroen Hoogland
摘要
While shrinkage is essential in high-dimensional settings, its use for low-dimensional regression-based prediction has been debated. It reduces variance, often leading to improved prediction accuracy. However, it also inevitably introduces bias, which may harm two other measures of predictive performance: calibration and coverage of confidence intervals. Here, the latter evaluates whether the amount of uncertainty is correctly quantified. Much of the criticism stems from the usage of standard shrinkage methods, such as lasso and ridge with a single, cross-validated penalty. Our aim is to show that readily available alternatives may improve predictive performance, in terms of accuracy, calibration or coverage. We study linear and logistic regression. For linear regression, we use small sample splits of a large, fairly typical epidemiological data set to illustrate that usage of differential ridge penalties for covariate groups may enhance prediction accuracy, while calibration and coverage benefit from additional shrinkage of the penalties. Bayesian hierarchical modeling facilitates the latter, including local shrinkage. In the logistic regression setting, we apply an external simulation to illustrate that local shrinkage may improve calibration with respect to global shrinkage, while providing better prediction accuracy than other solutions, like Firth’s correction. The potential benefits of the alternative shrinkage methods are easily accessible via example implementations in R , including the estimation of multiple penalties. A synthetic copy of the large data set is shared for reproducibility.
SMMR Survival Analysis · 发表于 2025-05-29
Gilbert Kiprotich, Diego Ignacio Gallardo, Pedro Luiz Ramos, Thomas Augustin
摘要
In this article, we propose a new frailty model based on a mixture of inverse Gaussian distributions for multivariate lifetimes. This approach provides an advantage over previous models, as the weights are directly determined through parameterization of the mixture, removing the need for arbitrary guesswork in the weighting process. Moreover, the closed-form Laplace transform of the model facilitates the quantification of Kendall’s tau measure of dependence. The frailty model’s parametric and flexible parametric variants are examined. For parameter estimation, the expectation-maximization technique is employed, taking advantage of the hierarchical representation of the frailty distribution, providing a simpler and more stable method than directly maximizing the observed log-likelihood function. The performance of the estimators is assessed numerically using Monte Carlo simulations. We apply our methodology to two medical datasets on cancer. The results indicate the benefits of the proposed model over existing frailty models in the literature. The implementation of the procedure is added to the R package extrafrail .
Biometrics Longitudinal Data Nonparametric & Semiparametric Diagnostics & Prediction · 发表于 2025-05-28
Yifei Sun, Xiwen Zhao, Kwun Chuen Gary Chan, Wanwan Xu, Heather Allore, Yize Zhao
摘要
Understanding how biomarkers change in relation to disease pathogenesis is a key area in biomedical research. We propose a semiparametric joint model to analyze the temporal evolution of biomarkers prior to the onset of disease. The model allows for a flexible biomarker trajectory that depends on two time scales: a natural time scale such as age and time to disease onset. In practice, the natural time scale often differs from time-on-study, leading to analytical challenges such as left-truncation bias. We introduce a profile kernel estimating equation approach to estimate regression coefficients and unspecified baseline mean trajectory functions. We establish the large-sample properties of the proposed estimators and conduct simulation studies to evaluate their finite-sample performance. Our method is applied to investigate brain biomarker trajectories before the onset of preclinical Alzheimer’s disease. We observed a decline in cortical thickness prior to disease onset across brain regions, with APOE4 carriers showing lower levels compared to non-carriers.
SiM Survival Analysis Longitudinal Data Diagnostics & Prediction · 发表于 2025-05-26
Zhenwei Yang, Dimitris Rizopoulos, Eveline A. M. Heijnsdijk, Lisa F. Newcomb, Nicole S. Erler
摘要
Active surveillance (AS), where biopsies are conducted to detect cancer progression, has been acknowledged as an efficient way to reduce the overtreatment of prostate cancer. Most AS cohorts use fixed biopsy schedules for all patients. However, the ideal test frequency remains unknown, and the routine use of such invasive tests burdens the patients. An emerging idea is to generate personalized biopsy schedules based on each patient's progression‐specific risk. To achieve that, we propose the interval‐censored cause‐specific joint model (ICJM), which models the impact of longitudinal biomarkers on cancer progression while considering the competing event of early treatment initiation. The underlying likelihood function incorporates the interval‐censoring of cancer progression, the competing risk of treatment, and the uncertainty about whether cancer progression occurred since the last biopsy in patients that are right‐censored or experience the competing event. The model can produce patient‐specific risk profiles up to a horizon time. If the risk exceeds a certain threshold, a biopsy is conducted. The optimal threshold can be chosen by balancing two indicators of the biopsy schedules: The expected number of biopsies and the expected delay in detection of cancer progression. A simulation study showed that our personalized schedules could considerably reduce the number of biopsies per patient by 41%–52% compared to the fixed schedules, though at the cost of a slightly longer detection delay.
SiM High-Dimensional Diagnostics & Prediction Latent Variables & Mixtures · 发表于 2025-05-26
Guanbo Wang, Sylvie Perreault, Robert W. Platt, Rui Wang, Marc Dorais, Mireille E. Schnitzer
摘要
Prediction models are important in medical research, as such models enable health researchers to gain deeper insights into disease epidemiology and clinicians to identify patients at higher risk of adverse outcomes. One commonly employed approach to developing prediction models is variable selection through penalized regression. Integrating natural variable structures and predefined inclusion requirements into variable selection not only enhances model interpretability but can also potentially boost prediction accuracy. For example, the latent overlapping group Lasso can force the inclusion of the main terms in the resulting model if their interaction term is selected. However, when variable structures are complex, it is challenging to integrate such structures into the penalized regression. In this work, we first demonstrate how to convert variable structures and predefined variable inclusion requirements into “selection rules” (which represent rules for which or how variables can be included in the final prediction model) and present these rules mathematically. Then, we provide a structured approach for integrating complex rules into variable selection through the latent overlapping group Lasso so that the resulting prediction model follows the given selection rules. To illustrate our methodology, we applied these techniques to construct a coherent prediction model for major bleeding in hypertensive patients recently hospitalized for atrial fibrillation and subsequently prescribed oral anticoagulants. In this application, we account for a proxy of anticoagulant adherence and its interaction with dosage and the type of oral anticoagulants, in addition to drug‐drug interactions.
Biometrics Testing & Uncertainty Survival Analysis · 发表于 2025-05-26
Jing Qin, Jin Piao, Jing Ning, Yu Shen
摘要
The distribution-free method of conformal prediction has gained considerable attention in computer science, machine learning, and statistics. Candès et al. extended this method to right-censored survival data, addressing right-censoring complexity by creating a covariate shift setting, extracting a subcohort of subjects with censoring times exceeding a fixed threshold. Their approach only estimates the lower prediction bound for type I censoring, where all subjects have available censoring times regardless of their failure status. In medical applications, we often encounter more general right-censored data, observing only the minimum of failure time and censoring time. Subjects with observed failure times have unavailable censoring times. To address this, we propose a bootstrap method to construct 1- as well as 2-sided conformal predictive intervals for general right-censored survival data under different working regression models. Through simulations, our method demonstrates excellent average coverage for the lower bound and good coverage for the 2-sided predictive interval, regardless of working model is correctly specified or not, particularly under moderate censoring. We further extend the proposed method to several directions in medical applications. We apply this method to predict breast cancer patients’ future survival times based on tumor characteristics and treatment.
Biometrics Survival Analysis Bayesian Methods · 发表于 2025-05-26
Md Tuhin Sheikh, Hongyu Zhao
摘要
Type 2 diabetes (T2D) is a major health concern worldwide with multiple disease stages, including onset, progression to complications, and death. Understanding the roles of genetic and nongenetic factors at different disease stages is crucial for gaining insights into disease etiology, possible prevention, and treatment strategies. The UK Biobank (UKB) is a valuable resource for studying complex diseases, including T2D, with comprehensive data from half a million volunteer participants. However, the UKB data present some unique challenges due to their semicompeting risks structure, involving 2 nonterminal events (T2D and complications) and one terminal event (death). In this paper, we propose a new shared gamma frailty-based semicompeting risks model within the Bayesian framework to account for subsequent nonterminal and terminal events and enable appropriate analysis. We further propose incorporating prevalent cases, that is, individuals with diabetes at enrollment, to gain more insights into the progression to complications and complications to death. To integrate prevalent cases, we introduce a power prior approach that leads to improved model fit and more efficient estimates. Simulation results demonstrate the efficacy of our modeling framework. We apply our method to identify the impacts of various risk factors at different stages of T2D development.
SiM Longitudinal Data Missing Data & Measurement Error · 发表于 2025-05-23
Masahiro Kondo, Kengo Nagashima, Shiroh Isono, Yasunori Sato
摘要
The relationship between two variables measured multiple times per individual has often been evaluated in clinical studies. These data are not independent; therefore, the Pearson correlation coefficient is inappropriate, and some correlation coefficients for these data have been proposed. However, in the presence of missing data, the existing methods can be biased. In this article, we proposed a weighted repeated measures correlation coefficient that provides an accurate estimate, even with missing data, in a study in which participants ideally have the same number of measurements. We also provided a bootstrap confidence interval for the weighted repeated measures correlation coefficients. We evaluated the performance of the proposed and existing methods (i.e., simple Pearson correlation coefficient, the Pearson correlation coefficient for average, average of the Pearson correlation coefficient, correlation coefficient based on analysis of covariance, and correlation coefficient based on the linear mixed‐effects model) through simulations and application to actual data. In numerical evaluations using simulations, the proposed method consistently outperformed existing methods. We recommend using a weighted repeated measures correlation coefficient to handle missing values in multiple‐measurement data.
Biometrics Latent Variables & Mixtures High-Dimensional Genetics & Omics · 发表于 2025-05-23
Daolin Pang, Ruoqing Zhu, Hongyu Zhao, Tao Wang
摘要
Rapid advances in high-throughput sequencing technologies have led to the fast accumulation of high-dimensional data, which is harnessed for understanding the implications of various factors on human disease and health. While dimension reduction plays an essential role in high-dimensional regression and classification, existing methods often require the predictors to be continuous, making them unsuitable for discrete data, such as presence-absence records of species in community ecology and sequencing reads in single-cell studies. To identify and estimate sufficient reductions in regressions with discrete predictors, we introduce probabilistic exponential family inverse regression (PrEFIR), assuming that, given the response and a set of latent factors, the predictors follow one-parameter exponential families. We show that the low-dimensional reductions result not only from the response variable but also from the latent factors. We further extend the latent factor modeling framework to the double exponential family by including an additional parameter to account for the dispersion. This versatile framework encompasses regressions with all categorical or a mixture of categorical and continuous predictors. We propose the method of maximum hierarchical likelihood for estimation, and develop a highly parallelizable algorithm for its computation. The effectiveness of PrEFIR is demonstrated through simulation studies and real data examples.
Biometrics Testing & Uncertainty · 发表于 2025-05-23
Ante Bing, Donna Spiegelman, Daniel Nevo, Judith J Lok
摘要
It is well known that changing the intervention package while a trial is ongoing does not lead to valid inference using standard statistical methods. However, it is often necessary to adapt, tailor, or tweak a complex intervention package in public health implementation trials, especially when the intervention package does not have the desired effect. This article presents conditions under which the resulting analyses remain valid even when the intervention package is adapted while a trial is ongoing. Our results on such Learn-As-you-GO (LAGO) trials extend the theory of LAGO for binary outcomes following a logistic regression model to LAGO for continuous outcomes under flexible conditional mean models. Because the mathematical methods for binary outcomes do not apply to continuous outcomes, the theory presented in this paper is entirely new. We derive point and interval estimators of the intervention effects and ensure the validity of hypothesis tests for an overall intervention effect. We develop a confidence set for the optimal intervention package, which achieves a pre-specified mean outcome while minimizing cost, and confidence bands for the mean outcome under all intervention package compositions. This work will be useful for the design and analysis of large-scale intervention trials where the intervention package is adapted, tailored, or tweaked while the trial is ongoing.
Biometrics Causal Inference Longitudinal Data · 发表于 2025-05-23
Kateline Le Bourdonnec, Linda Valeri, Cécile Proust-Lima
摘要
Mediation analysis aims to decipher the underlying causal mechanisms between an exposure, an outcome, and intermediate variables called mediators. Initially developed for fixed-time mediator and outcome, it has been extended to the framework of longitudinal data by discretizing the assessment times of mediator and outcome. Yet, processes in play in longitudinal studies are usually defined in continuous time and measured at irregular and subject-specific visits. This is the case in dementia research when cerebral and cognitive changes measured at planned visits in cohorts are of interest. We thus propose a methodology to estimate the causal mechanisms between a time-fixed exposure ($X$), a mediator process ($\mathcal {M}_t$), and an outcome process ($\mathcal {Y}_t$) both measured repeatedly over time in the presence of a time-dependent confounding process ($\mathcal {L}_t$). We consider 2 types of causal estimands, the natural effects and path-specific effects. We provide identifiability assumptions, and we employ a multivariate mixed model based on differential equations for their estimation. The performances of the method are assessed in simulations, and the method is illustrated in 2 real-world examples motivated by the 3C cerebral aging study to assess (1) the effect of educational level on functional dependency through depressive symptomatology and cognitive functioning and (2) the effect of a genetic factor on cognitive functioning potentially mediated by vascular brain lesions and confounded by neurodegeneration.
SiM Clinical Trials Testing & Uncertainty High-Dimensional · 发表于 2025-05-22
Lukas Pin, Oleksandr Sverdlov, Frank Bretz, Björn Bornkamp
摘要
Dose selection is critical in pharmaceutical drug development, as it directly impacts therapeutic efficacy and patient's safety of a drug. The Generalized Multiple Comparison Procedures and Modeling approach is commonly used in Phase II trials for testing and estimation of dose‐response relationships. However, its effectiveness in small sample sizes, particularly with binary endpoints, is hindered by issues like complete separation in logistic regression, leading to non existence of estimates. Motivated by an actual clinical trial using the MCP‐Mod approach, this paper introduces penalized maximum likelihood estimation (MLE) and randomization‐based inference techniques to address these challenges. Randomization‐based inference allows for exact finite sample inference, while population‐based inference for MCP‐Mod typically relies on asymptotic approximations. Simulation studies demonstrate that randomization‐based tests can enhance statistical power in small to medium‐sized samples while maintaining control over type‐I error rates, even in the presence of time trends. Our results show that residual‐based randomization tests using penalized MLEs not only improve computational efficiency but also outperform standard randomization‐based methods, making them an adequate choice for dose‐finding analyses within the MCP‐Mod framework. Additionally, we apply these methods to pharmacometric settings, demonstrating their effectiveness in such scenarios. The results in this paper underscore the potential of randomization‐based inference for the analysis of dose‐finding trials, particularly in small sample contexts.
SiM Missing Data & Measurement Error · 发表于 2025-05-22
Arielle Marks‐Anglin, Jianmin Chen, Chongliang Luo, Rebecca Hubbard, Yong Chen
摘要
Electronic Health Record (EHR) databases are an increasingly valuable resource for observational studies. However, misclassification of EHR‐derived outcomes due to imperfect phenotyping leads to bias, inflated type I error, and reduced power in risk‐factor association studies. On the other hand, manual chart review to validate outcomes is both cost‐prohibitive and time‐consuming, and a randomly selected validation sample may not yield sufficient cases to support precise model estimation when the disease is rare. Sampling procedures have been developed for maximizing computational and statistical efficiency in settings where the true disease status is known. However, less work has been done in measurement constrained settings, particularly when an informative surrogate outcome is available. Motivated by this gap, we propose an Optimal Subsampling strategy with Surrogate‐Assisted Two‐step procedure (OSSAT) to guide cost‐effective chart review in measurement constrained settings. The sampling weight in OSSAT leverages information contained in the potentially misclassified phenotype and covariates to prioritize observations most informative for the model of interest. We compare our proposed weight with existing approaches through simulations under various covariate distributions, differential misclassification rates and degrees of surrogate accuracy. We then apply our proposed weighting schemes to a study of risk factors for second breast cancer events using a real EHR data set.
JASA Networks & Graphs Genetics & Omics · 发表于 2025-05-22
Yaoming Zhen, Jin-Hong Du
摘要
Given the ubiquity of modularity in biological systems, module-level regulation analysis is vital for understanding biological systems across various levels and their dynamics. Current statistical analysis on biological modules predominantly focuses on either detecting the functional modules in biological networks or sub-group regression on the biological features without using the network data. This paper proposes a novel network-based neighborhood regression framework whose regression functions depend on both the global community-level information and local connectivity structures among entities. An efficient community-wise least square optimization approach is developed to uncover the strength of regulation among the network modules while enabling asymptotic inference. With random graph theory, we derive non-asymptotic estimation error bounds for the proposed estimator, achieving exact minimax optimality. Unlike the root-n consistency typical in canonical linear regression, our model exhibits linear consistency in the number of nodes n, highlighting the advantage of incorporating neighborhood information. The effectiveness of the proposed framework is further supported by extensive numerical experiments. Application to whole-exome sequencing and RNA-sequencing Autism datasets demonstrates the usage of the proposed method in identifying the association between the gene modules of genetic variations and the gene modules of genomic differential expressions. *(abstract via OpenAlex)*
SiM Survival Analysis Causal Inference · 发表于 2025-05-22
Zhizhen Zhao, Ai Ni, Xinyi Xu, Macarius Donneyong, Bo Lu
摘要
Individualized treatment rules (ITRs) tailor treatments to individuals based on their unique characteristics to optimize clinical outcomes and resource allocation. Current approaches use outcome modeling or propensity score weighting to control confounding in complex medical data. To avoid model misspecification and the impact of extreme weights, matched‐learning (M‐learning) was recently proposed for continuous outcomes. In this paper, we expand the existing M‐learning methodology to estimate optimal ITRs under right‐censored data, as time‐to‐event outcomes are common in medical research. We construct matched sets for individuals by comparing observed times and incorporate an inverse probability censoring weight into the value function to handle censored observations. Additionally, we consider a full matching design as a possible alternative to the matching with replacement in M‐learning. We demonstrate that the proposed value function is unbiased for the true value function without censoring. To gain insight into the empirical performance, we conduct an extensive simulation study that compares M‐learning with two matching designs and a weighed learning approach. Results are evaluated based on winning probabilities and estimated values. The simulation reveals that all methods are generally fine in the absence of unmeasured confounders, and different methods show somewhat different performances under various scenarios. But their performance drops substantially in the presence of unmeasured confounders. Finally, we apply these methods to estimate optimal ITRs for patients with atrial fibrillation (AF) complications from an electronic medical record database, where full matching design shows slightly better performance.
JASA Testing & Uncertainty Spatial & Time Series · 发表于 2025-05-22
Yi Zhang, Xiaofeng Shao
摘要
Testing simple or composite hypothesis on a functional parameter has attracted considerable attention in time series analysis. To accommodate for the unknown temporal dependence, classical nonparametric approaches such as block bootstrapping and subsampling all involve a bandwidth parameter, the choice of which can substantially affect the finite sample performance. The self normalization (SN) method is tuning parameter free when applied to the inference of a finite-dimensional parameter but its applicability to a functional parameter is unknown.In this paper, we propose a sample splitting based approach to generalize the SN method to hypothesis testing of a functional parameter. Our SS-SN (sample splitting plus self-normalization) idea is broadly applicable to many testing problems for functional parameters, including testing for simple/composite hypothesis on marginal cumulative distribution function, testing for time-reversibility and testing for a change point on the spectral distribution of a multivariate time series. Specifically, we derive the pivotal limiting distributions of our SS-SN test statistics under the null for both simple and composite null hypothesis, and derive the limiting power function under the local alternatives. Numerical simulations show that our new tests tend to yield accurate size with competitive power performance as compared to many existing ones. *(abstract via OpenAlex)*
JASA Spatial & Time Series Nonparametric & Semiparametric Testing & Uncertainty · 发表于 2025-05-22
Myungjin Kim, Li Wang, Huixia Judy Wang
摘要
This paper presents a flexible quantile spatially varying coefficient model (QSVCM) for the regression analysis of spatial data. The proposed model enables researchers to assess the dependence of conditional quantiles of the response variable on covariates while accounting for spatial nonstationarity. Our approach facilitates learning and interpreting heterogeneity in spatial data distributed over complex or irregular domains. We introduce a quantile regression method that utilizes bivariate penalized splines in triangulation to estimate unknown functional coefficients. We establish the L 2 convergence of the proposed estimators, demonstrating their optimal convergence rate under certain regularity conditions. An efficient optimization algorithm is developed using the alternating direction method of multipliers (ADMM). We develop wild residual bootstrap-based pointwise confidence intervals for the QSVCM quantile coefficients. Furthermore, we construct reliable conformal prediction intervals for the response variable using the proposed QSVCM. Simulation studies show the remarkable performance of the proposed methods. Lastly, we illustrate the practical applicability of our methods by analyzing the mortality dataset and the supplementary particulate matter (PM) dataset in the United States. *(abstract via PubMed)*
SiM Spatial & Time Series · 发表于 2025-05-22
Yun Lin, Xiaoran Yang, Fangfang Bai
摘要
The mean residual life model offers comprehensive insights into the relationship between a patient's remaining life expectancy and various covariates. In cancer research, a patient's lifespan may dramatically change when a covariate exceeds a threshold. Accurately detecting and estimating this change‐point is crucial for predicting the patient's life expectancy and preventing diseases. To address these challenges, we investigate the additive mean residual life model with an unknown change‐point in the continuous covariate. The martingale‐based smoothed estimating equations are used to estimate the baseline mean residual life function, regression parameters, and the unknown change‐point. Furthermore, we establish the large sample properties of the estimator under mild conditions, and propose a maximal Wald test statistic to test the existence of the change‐point. Finally, we assess the finite sample performance of our proposed method through extensive simulation studies and apply it to two real data examples from studies on stomach cancer and primary biliary cirrhosis. Supplementary materials for this article are available online.
SiM Nonparametric & Semiparametric · 发表于 2025-05-22
Yiwei Li, Yuyan Wang, Akhgar Ghassabian, Leonardo Trasande, Mengling Liu
摘要
Environmental exposures often exhibit temporal variability, prompting extensive research to understand their dynamic impacts on human health. There has been a growing interest in studying time‐dependent exposure mixtures beyond a single exposure. However, current analytic methods typically assess each exposure individually or assume an additive relationship. This paper aims to fill the gap in method development for evaluating the joint effects of multiple time‐dependent exposures on a scalar outcome. We introduce a dynamic single‐index scalar‐on‐function model to characterize the exposure mixture's time‐varying effect through a non‐parametric bivariate exposure‐time‐outcome surface function. Utilizing B‐spline tensor product bases to approximate the surface function, we propose a profiling algorithm for model estimation and establish large‐sample properties for the resulting single‐index estimators. In addition, we introduce a non‐parametric hypothesis testing procedure to determine whether the surface function varies over time at each fixed mixture level and a model averaging solution to circumvent the issue of knot selection for spline approximations. The performance of our proposed methods is examined through extensive simulations and further illustrated using real‐world applications.
JASA Meta-Analysis & Data Integration · 发表于 2025-05-22
Elynn Chen, Xi Chen, Wenbo Jing, Yichen Zhang
摘要
As tensors become widespread in modern data analysis, Tucker low-rank Principal Component Analysis (PCA) has become essential for dimensionality reduction and structural discovery in tensor datasets. Motivated by the common scenario where large-scale tensors are distributed across diverse geographic locations, this paper investigates tensor PCA within a distributed framework where direct data pooling is theoretically suboptimal or practically infeasible.We offer a comprehensive analysis of three specific scenarios in distributed Tensor PCA: a homogeneous setting in which tensors at various locations are generated from a single noise-affected model; a heterogeneous setting where tensors at different locations come from distinct models but share some principal components, aiming to improve estimation across all locations; and a targeted heterogeneous setting, designed to boost estimation accuracy at a specific location with limited samples by utilizing transferred knowledge from other sites with ample data.We introduce novel estimation methods tailored to each scenario, establish statistical guarantees, and develop distributed inference techniques to construct confidence regions. Our theoretical findings demonstrate that these distributed methods achieve sharp rates of accuracy by efficiently aggregating shared information across different tensors, while maintaining reasonable communication costs. Empirical validation through simulations and real-world data applications highlights the advantages of our approaches, particularly in managing heterogeneous tensor data. *(abstract via OpenAlex)*
SiM Clinical Trials Testing & Uncertainty · 发表于 2025-05-22
Dipro Mondal, Math J J M Candel, Alberto Cassese, Sophie Vanbelle
摘要
The reliability of measurement instruments is vital in fields like medicine and psychology, where these tools are often used for diagnostic purposes. In reliability studies where participants are assessed by the same set of raters, the data can be modeled using a two‐way ANOVA, with the intraclass correlation coefficient (ICC) as a key metric. This paper focuses on the ICC for agreement, which is crucial when the measurement values themselves, rather than just their rank ordering, are of interest. However, selecting appropriate confidence interval methods and determining adequate sample sizes for the ICC for agreement remains challenging. This work advances the understanding of confidence interval methods for the ICC for agreement, provides practical tools, and offers recommendations for selecting confidence interval methods and sample size procedures for planning reliability studies. In particular, we provide a comprehensive review and simulation‐based comparison of six classes of confidence interval methods for the ICC for agreement identified in the literature. Our analysis includes a method based on the F‐distribution, previously omitted, which demonstrates the best statistical properties in some cases. Then, in conjunction with the best‐performing methods, we evaluate three sample size determination procedures based on the expected width of confidence intervals that we identified in the literature. To address the lack of accessible tools, we further developed an interactive R Shiny app, freely available to researchers, to compute confidence intervals and sample sizes. The utility of these methods is illustrated by a study on fetal heart rates.
SiM Clinical Trials · 发表于 2025-05-22
Ke Yang, Enxuan Lin, Wangli Xu, Liping Zhu, Tiejun Tong
摘要
Quantifying the heterogeneity is an important issue in meta‐analysis, and among the existing measures, the statistic is most commonly used. In this article, we first illustrate with a simple example that the statistic is heavily dependent on the study sample sizes, mainly because it is used to quantify the heterogeneity between the observed effect sizes. To reduce the influence of sample sizes, we introduce an alternative measure that aims to directly measure the heterogeneity between the study populations involved in the meta‐analysis. We further propose a new estimator, namely the statistic, to estimate the newly defined measure of heterogeneity. For practical implementation, the exact formulas of the statistic are also derived under two common scenarios with the effect size as the mean difference (MD) or the standardized mean difference (SMD). Simulations and real data analyses demonstrate that the statistic provides an asymptotically unbiased estimator for the absolute heterogeneity between the study populations, and it is also independent of the study sample sizes as expected. To conclude, our newly defined statistic can be used as a supplemental measure of heterogeneity to monitor the situations where the study effect sizes are indeed similar with little biological difference. In such scenario, the fixed‐effect model can be appropriate; nevertheless, when the sample sizes are sufficiently large, the statistic may still increase to 1 and subsequently suggest the random‐effects model for meta‐analysis.
SiM Causal Inference Survival Analysis · 发表于 2025-05-22
Yuhao Deng, Rui Wang
摘要
Inverse probability of treatment weighting (IPW) has been well applied in causal inference to estimate population‐level estimands from observational studies. For time‐to‐event outcomes, the failure time distribution can be estimated by estimating the cumulative hazard in the presence of random right censoring. IPW can be performed by weighting the event counting process and at‐risk process by the inverse treatment probability, resulting in an adjusted Nelson–Aalen estimator for the population‐level counterfactual cumulative incidence function. We consider the adjusted Nelson–Aalen estimator with an estimated propensity score in the competing risks setting. When the estimated propensity score is regular and asymptotically linear, we derive the influence functions for the counterfactual cumulative hazard and cumulative incidence. Then we establish the asymptotic properties for the estimators. We show that the uncertainty in the estimated propensity score contributes to an additional variation in the estimators. However, through simulation and real‐data application, we find that such an additional variation is usually small.
SiM Clinical Trials Bayesian Methods · 发表于 2025-05-22
Chloe E. Falke, Joseph S. Koopmeiners
摘要
Intra‐patient dose escalation (IPDE) provides a strategy for more efficient Phase I clinical trials. However, IPDE poses additional challenges due to the need to account for carryover toxicity from previous dosings a patient has received. To that end, we propose two CRM–based approaches to IPDE that incorporate potential carryover toxicity. We compare these methods to the CRM without IPDE and the AIDE‐CRM, an existing Bayesian adaptive approach to IPDE. In simulations across a range of scenarios, we show that our approaches have similar operating characteristics to the CRM without IPDE, but with a 20% reduction in time and participants needed to complete the trial; these results hold even in the presence of strong carryover toxicity that hinders the performance of the AIDE‐CRM.
SiM Clinical Trials Diagnostics & Prediction Bayesian Methods · 发表于 2025-05-22
Yuan Li, Dejian Lai, Ruosha Li, Han Chen, Xuelin Huang, Jing Ning
摘要
Targeted cancer therapies aim to effectively treat patients with specific biomarker profiles. Nevertheless, these therapies may not always precisely hit their intended targets, leading to uncertainty about the specific subset of patients who will benefit. To address this uncertainty, the identification of sensitive patient subsets in clinical trials becomes crucial. Our proposed phase IIB/III clinical trial design seeks to pinpoint a biomarker signature with precision, ensuring the accurate identification of patients who will respond to a specific treatment. This approach allows for the selective enrollment of sensitive patients to maximize benefits for trial participants. We incorporate Bayesian methodology to facilitate response‐adaptive randomization, enhancing the likelihood that each participant receives his/her optimal treatment. Furthermore, our design uses inverse‐probability‐of‐treatment‐weighted analysis to avoid selection bias and control for the type I error rate. The evaluation of this trial design is based on four criteria: the statistical power, response rate of all patients participating in the current trial, their individual loss, and probabilities of receiving their optimal treatment for both current trial participants and future patients. Simulations demonstrate the proposed design's potential for maximizing trial participants' benefits with little sacrifice on statistical power. Its key advantages include an improved overall response rate within the trial and a higher percentage of patients receiving the optimal treatment.
JASA Bayesian Methods High-Dimensional Latent Variables & Mixtures · 发表于 2025-05-21
Jiguang Li, Robert Gibbons, Veronika Ročková
摘要
Multivariate Item Response Theory (MIRT) is sought-after widely by applied researchers looking for interpretable (sparse) explanations underlying response patterns in questionnaire data. There is, however, an unmet demand for such sparsity discovery tools in practice. Our article develops a Bayesian platform for binary and ordinal item MIRT which requires minimal tuning and scales well on large datasets due to its parallelizable features. Bayesian methodology for MIRT models has traditionally relied on MCMC simulation, which cannot only be slow in practice, but also often renders exact sparsity recovery impossible without additional thresholding. In this work, we develop a scalable Bayesian EM algorithm to estimate sparse factor loadings from mixed continuous, binary, and ordinal item responses. We address the seemingly insurmountable problem of unknown latent factor dimensionality with tools from Bayesian nonparametrics which enable estimating the number of factors. Rotations to sparsity through parameter expansion further enhance convergence and interpretability without identifiability constraints. In our simulation study, we show that our method reliably recovers both the factor dimensionality as well as the latent structure on high-dimensional synthetic data even for small samples. We demonstrate the practical usefulness of our approach on three datasets: an educational assessment dataset, a quality-of-life measurement dataset, and a bio-behavioral dataset. All demonstrations show that our tool yields interpretable estimates, facilitating interesting discoveries that might otherwise go unnoticed under a pure confirmatory factor analysis setting. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*
SiM Genetics & Omics Survey & Sampling Meta-Analysis & Data Integration 讨论 / 评论 · 发表于 2025-05-21
RuoFei Yin, George C. Tseng
摘要
We agree and highly appreciate the correction of the non‐central parameter (ncp) in the power calculation by Dr. Westermark. We acknowledge the mathematical mistake in our derivation. As indicated in the commentary, under the “evenly spaced sampling design” (e.g., sampling every 2 h for 24 h with four biological replicates at each time point; samples), discrepancy of the non‐central parameter and the resulting statistical power between the corrected calculation and ours is 0. Below, we conduct further simulations to investigate the degree of statistical power miscalculation in “unevenly‐spaced sampling design” in case potential users may have applied our formula in their experimental planning. We consider two types of sampling designs throughout the 24 h of a day: (i) Uniformly distributed (uniform): ; (ii) Unimodal Gaussian distributed (unimodal): with . The following figure shows results for amplitude‐to‐noise ratio and phase . Note that results of are identical to due to symmetry. As expected, for uniformly or almost uniformly distributed designs (i.e., Uniform, Unimodal‐sd6, and Unimodal‐sd8), the difference between the corrected and previous power calculations is 0 or close to 0. For moderate to extremely uneven distributed design (Unimodal‐sd2 and Unimodal‐sd4), the discrepancies become more and more substantial. The previous incorrect npc tends to inflate the estimated statistical power. We have updated the CircaPower R package on the Github ( https://github.com/circaPower/circaPower), highlighted the correction, and cited the commentary paper.
SMMR Bayesian Methods · 发表于 2025-05-21
Ornella Moro, Inger Torhild Gram, Maja-Lisa Løchen, Marit B Veierød, Ana Maria Wägner, Giovanni Sebastiani
摘要
Future occurrence of a disease can be highly influenced by some specific risk factors. This work presents a comprehensive approach to quantify the event probability as a function of each separate risk factor by means of a parametric model. The proposed methodology is mainly described and applied here in the case of a linear model, but the non-linear case is also addressed. To improve estimation accuracy, three distinct methods are developed and their results are integrated. One of them is Bayesian, based on a non-informative prior. Each of the other two, uses aggregation of sample elements based on their factor values, which is optimized by means of a different specific criterion. For one of these two, optimization is performed by Simulated Annealing. The methodology presented is applicable across various diseases but here we quantify the risk for cardiovascular diseases in subjects with type 1 diabetes. The results obtained combining the three different methods show accurate estimates of cardiovascular risk variation rates for the factors considered. Furthermore, the detection of a biological activation phenomenon for one of the factors is also illustrated. To quantify the performances of the proposed methodology and to compare them with those from a known method used for this type of models, a large simulation study is done, whose results are illustrated here.
SiM Genetics & Omics · 发表于 2025-05-21
Pål O. Westermark
摘要
We read with great interest the article by Zong et al. [1], where the authors explored the statistical power of the standard cosinor model for detection of biological rhythms with a focus on circadian rhythms and its implications for experimental design, that is, the choice of the circadian time or zeitgeber time (ZT) points at which measurements are made.As the authors rightfully point out, power analysis has been an overlooked topic in chronobiology and biological rhythms research.Except for being necessary for the planning and design of experiments, power analysis has the additional potential to explain, for example, inconsistencies and a certain lack of reproducibility in studies of circadian or diurnal rhythmicity in gene expression [2,3].However, we must conclude that the expression for the noncentrality parameter that is necessary to compute power has an incorrect form (part of Theorem 2 in their article), which affects all cases when the experimental design is non-centered (see below for precise definition of centered design in the context of the cosinor model).Here, we present a correct derivation of the noncentrality parameter, which requires some extra steps.As we further show, the resulting discrepancy between the correct and incorrect forms in computed power can be large.However, for the data analyses presented by Zong et al. [1], we do not foresee large discrepancies, so that their results for non-centered designs probably still hold qualitatively, although that would need to be numerically verified in a rigorous manner. *(abstract via OpenAlex)*
SiM Other · 发表于 2025-05-20
Karen M. Higgins, Jyoti Zalkikar, Jialu Zhang, Yan Wang, Rebecca Chiu, Mat Soukup, Yeh‐Fong Chen, Greg Levin
摘要
There are different reasons to include futility monitoring in clinical trials. We often think of futility monitoring as being planned for business decisions, to limit time and money in a trial that will likely fail its primary objective. But there are also public health and ethical reasons for conducting, or not conducting, futility monitoring in clinical trials. Important considerations in futility monitoring include maintenance of trial integrity, the methods used and their operating characteristics, and the interplay with safety monitoring. This article will discuss some of the whys, whens, and hows of futility monitoring.
JASA Other · 发表于 2025-05-20
Shirong Xu, Will Wei Sun, Guang Cheng
摘要
In various real-world scenarios, such as recommender systems and political surveys, pairwise rankings are commonly collected and used for rank aggregation to derive an overall ranking of items. However, preference rankings can reveal individuals’ personal preferences, highlighting the need to protect them from exposure in downstream analysis. In this article, we address the challenge of preserving privacy while ensuring the utility of rank aggregation based on pairwise rankings generated from a general comparison model. A common privacy protection strategy in practice is the use of the randomized response mechanism to perturb raw pairwise rankings. However, a critical challenge arises because the privatized rankings no longer adhere to the original model, resulting in significant bias in downstream rank aggregation tasks. To address this, we propose an adaptive debiasing method for rankings from the randomized response mechanism, ensuring consistent estimation of true preferences and enhancing the utility of downstream rank aggregation. Theoretically, we provide insights into the relationship between overall privacy guarantees and estimation errors in private ranking data, and establish minimax rates for estimation errors. This enables the determination of optimal privacy guarantees that balance consistency in rank aggregation with privacy protection. We also investigate convergence rates of expected ranking errors for partial and full ranking recovery, quantifying how privacy protection affects the specification of top-K item sets and complete rankings. Our findings are validated through extensive simulations and a real-world application. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*
SiM Clinical Trials Causal Inference · 发表于 2025-05-20
Thomas R. Fleming, Kevin J. Carroll, Janet T. Wittes, Scott S. Emerson, Mark D. Rothmann, Sylva Collins, Gregory Levin
摘要
In randomized clinical trials, stopping study medication, use of rescue treatment, and other intercurrent events can complicate interpretation of results. The ICH E9(R1) Addendum on estimands stimulated important cross‐disciplinary discussions on trial objectives. Unfortunately, with influence of the Addendum, many trials have proposed analyzing primary endpoints using “while on treatment”, “hypothetical”, or “principal stratum” strategies that handle intercurrent events in ways that use post‐randomization outcomes to exclude information from randomized participants and don't preserve integrity of randomization, or that don't reliably capture the intervention's meaningful net effects. These approaches have inherent limitations in ability to draw scientifically rigorous inference on clinically relevant causal effects important for decisions about adopting interventions. We describe advantages of trials with standard‐of‐care control arms targeting estimands using “treatment policy” approaches for intercurrent events, while potentially incorporating other meaningful intercurrent events, such as death, into the primary endpoint applying a composite strategy. Well‐designed and ‐conducted trials targeting such estimands achieve scientifically rigorous causal inference through analyzes that protect the integrity of randomization. Such estimands also provide meaningful information relevant to real‐world settings because they (1) are unconditional in nature i.e., they don't condition on post‐treatment circumstances that might not be many participants' experiences; and (2) properly evaluate the experimental intervention within a regimen that includes possible ancillary care that would be clinically appropriate in real‐world settings. We hope to add clarity about appropriate strategies for intercurrent events and how to improve design, conduct, and analysis of clinical trials to address questions of greatest clinical importance reliably.
SiM Longitudinal Data · 发表于 2025-05-19
Rose H. Garrett, Masum Patel, Brian M. Feldman, Eleanor M. Pullenayegum
摘要
Electronic health records (EHRs) provide an efficient approach to generating rich longitudinal datasets. However, since patients visit as needed, the assessment times are typically irregular and may be related to the patient's health. Failing to account for this informative assessment process could result in biased estimates of the disease course. In this paper, we show how estimation of the disease trajectory can be enhanced by leveraging an underutilized piece of information that is often in the patient's EHR: physician‐recommended intervals between visits. Specifically, we demonstrate how recommended intervals can be used in characterizing the assessment process and in investigating the sensitivity of the results to assessment not at random (ANAR). We illustrate our proposed approach in a clinic‐based cohort study of juvenile dermatomyositis (JDM). In this study, we found that the recommended intervals explained 78% of the variability in the assessment times. Under a specific case of ANAR where we assumed that a worsening in disease led to patients visiting earlier than recommended, the estimated population average disease activity trajectory was shifted downward relative to the trajectory assuming assessment at random. These results demonstrate the crucial role recommended intervals play in improving the rigor of the analysis by allowing us to assess both the plausibility of the AAR assumption and the sensitivity of the results to departures from this assumption. Thus, we advise that studies using irregular longitudinal data should extract recommended visit intervals and follow our procedure for incorporating them into analyses.